鼎際得(603255.SH):近日將向下遊目標客戶發送公司自產的POE粒子進行產品準入與認證
格隆匯6月17日丨鼎際得(603255.SH)在互動平臺表示,鼎際得深耕聚烯烴行業20餘年,積累了廣泛良好的下遊客戶關係,特別是在抗氧劑的下遊應用客戶與POE粒子的下遊客戶羣體大量重疊,使得公司在目標客戶的拓展上擁有得天獨厚的基礎。同時,公司通過客戶拜訪,橡塑展等多種形式與光伏膠膜領域與摻混改性領域的多家主流廠商建立了良好的聯繫。隨着中試產品的成功我們近日將向下遊目標客戶發送公司自產的POE粒子進行產品準入與認證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.